Company & Sponsor Intelligence

University of Southern California

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials11

Recruiting1

Completed8

Countries1

Therapeutic footprint

alzheimersanxietyautismdementia_otherdepressionepilepsymultiple_sclerosispain_neuropathystroke

Indexed studies

NCT01767909The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
alzheimers · United StatesPHASE2, PHASE3

NCT07430800Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety
anxiety · United StatesNA

NCT05179083Exercise for Brain Regeneration in Epilepsy
epilepsy · United StatesPHASE1

NCT03111394Study of myMS in Participants With a Diagnosis of Multiple Sclerosis
multiple_sclerosis · United StatesCOMPLETED

NCT01231971Alzheimer's Disease Neuroimaging Initiative 2
alzheimers · United StatesCOMPLETED

NCT02488720Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
dementia_other · United StatesCOMPLETED

NCT03104816The Effectiveness of IV/PO Acetaminophen in the Perioperative Period in Reducing Opiate Use After Lumbar Spine Fusion
pain_neuropathy · United StatesPHASE4

NCT02430051Sensory Adapted Dental Environments to Enhance Oral Care for Children
autism · United StatesNA

NCT00709150Collaborative Depression Care Management in Treating Depressed Low-income Hispanics With Diabetes
depression · United StatesPHASE4

NCT05602220Heart Rate and Breathing Effects on Attention and Memory
alzheimers · United StatesNA

NCT05029193Effectiveness of Mindfulness After a Stroke
stroke · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →